BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10068736)

  • 1. [Gastric neuroendocrine tumor].
    Díaz-Sánchez CL; Molano Romero RA; Martínez González M; Márquez Rivera ML; Halabe-Cherem J
    Rev Gastroenterol Mex; 1998; 63(2):97-100. PubMed ID: 10068736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids.
    Jianu CS; Fossmark R; Syversen U; Hauso Ø; Fykse V; Waldum HL
    Scand J Gastroenterol; 2011 Apr; 46(4):456-63. PubMed ID: 21133821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic aspects of gastric neuroendocrine tumors.
    Rindi G
    Am J Surg Pathol; 1995; 19 Suppl 1():S20-9. PubMed ID: 7762736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gastric carcinoid in chronic atrophic gastritis with hypergastrinemia].
    Höring E; Egner E; von Gaisberg U
    Leber Magen Darm; 1991 Mar; 21(2):83-6. PubMed ID: 2038230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastric neuroendocrine tumors: clinical, endoscopic presentation and alternatives of treatment].
    Lazarte R; Poniachik J; Smok G; Contreras J; Gutiérrez L; Csendes A
    Rev Med Chil; 2002 Sep; 130(9):985-92. PubMed ID: 12434645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple carcinoid tumors of the stomach with hypergastrinemia.
    Nosaka T; Habu H; Endo M; Okayasu I
    Am J Gastroenterol; 1992 Jun; 87(6):766-70. PubMed ID: 1590318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors.
    Safatle-Ribeiro AV; Ribeiro U; Corbett CE; Iriya K; Kobata CH; Sakai P; Yagi OK; Pinto PE; Zilberstein B; Gama-Rodrigues J
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):21-8. PubMed ID: 17206073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
    Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
    Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroendocrine tumors of the stomach. Surgery therapy and prognosis].
    Bektas H; Länger F; Piso P; Werner U; Musholt TJ; Lehner F; Becker T; Klempnauer J
    Chirurg; 2002 Apr; 73(4):331-5. PubMed ID: 12063917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation, treatment, and outcome of type 1 gastric carcinoid tumors.
    Dakin GF; Warner RR; Pomp A; Salky B; Inabnet WB
    J Surg Oncol; 2006 Apr; 93(5):368-72. PubMed ID: 16550587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroendocrine tumors of the stomach (stomach carcinoid)].
    Federmann M; Bansky G; Flury R
    Schweiz Rundsch Med Prax; 1994 Sep; 83(39):1084-8. PubMed ID: 7939075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history, clinicopathologic classification and prognosis of gastric ECL cell tumors.
    Solcia E; Rindi G; Paolotti D; Luinetti O; Klersy C; Zangrandi A; La Rosa S; Capella C
    Yale J Biol Med; 1998; 71(3-4):285-90. PubMed ID: 10461359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multifocal carcinoid of the stomach].
    Poletti EM; Guffanti Pesenti G; Giovanelli A; Farina C; Vescovi L; Ghislandi R; Sonzogni A
    Minerva Chir; 1996 May; 51(5):341-6. PubMed ID: 9072743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological, molecular, and prognostic aspects of gastric endocrine tumors.
    Solcia E; Rindi G; Larosa S; Capella C
    Microsc Res Tech; 2000 Mar; 48(6):339-48. PubMed ID: 10738315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of multicentric gastric carcinoids without hypergastrinemia.
    Moriyama T; Matsumoto T; Hizawa K; Esaki M; Lwai K; Yao T; Iida M
    Endoscopy; 2003 Jan; 35(1):86-8. PubMed ID: 12510233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stomach carcinoid associated with chronic atrophic corpus gastritis in pernicious anemia].
    Papageorgiou A; Meyer-Papageorgiou S; Tzartinoglou E; Tzioufa V; Katsochis C
    Chirurg; 1995 Mar; 66(3):224-6. PubMed ID: 7750395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CCN2/CTGF in the proliferation of Mastomys enterochromaffin-like cells and gastric carcinoid development.
    Kidd M; Modlin IM; Eick GN; Camp RL; Mane SM
    Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G191-200. PubMed ID: 16950763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pernicious anemia and gastric carcinoid tumor: case report and review.
    Sculco D; Bilgrami S
    Am J Gastroenterol; 1997 Aug; 92(8):1378-80. PubMed ID: 9260813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of ECL cell carcinoids with octreotide LAR.
    Fykse V; Sandvik AK; Qvigstad G; Falkmer SE; Syversen U; Waldum HL
    Scand J Gastroenterol; 2004 Jul; 39(7):621-8. PubMed ID: 15370681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the serum gastrin 17 level: an evidence-based analysis of 3906 serum samples among Chinese.
    Zhang Z; Sun Lp; Gong YH; Wang XG; Zhang M; Yuan Y
    J Dig Dis; 2007 May; 8(2):72-6. PubMed ID: 17532818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.